Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory…
Global Times: China's No.1 central document in starting year of 15th Five-Year Plan sets agricultural modernization roadmap, turning rural potential into growth momentum
BEIJING, Feb. 5, 2026 /PRNewswire/ — China unveiled its "No.1 central document"…